AN UPDATE ON CLINICAL AND ECONOMIC EVIDENCE REQUIREMENTS FOR ADVANCED-THERAPY MEDICINAL PRODUCTS IN EUROPE

被引:2
|
作者
Anastasaki, E. [1 ]
Walker, A. [2 ]
Bradshaw, S. [1 ]
机构
[1] Market Access Solut LLC, London, England
[2] Univ Glasgow, Glasgow, Lanark, Scotland
关键词
D O I
10.1016/j.jval.2014.08.1176
中图分类号
F [经济];
学科分类号
02 ;
摘要
PHP240
引用
收藏
页码:A444 / A444
页数:1
相关论文
共 50 条
  • [41] GMP Challenges for Advanced Therapy Medicinal Products
    Milmo, Sean
    BIOPHARM INTERNATIONAL, 2015, 28 (12) : 12 - 14
  • [42] Education for the translation of Advanced Therapy Medicinal Products
    Adamo, Davide
    Attico, Eustachio
    Pellegrini, Graziella
    FRONTIERS IN MEDICINE, 2023, 10
  • [43] Pharmacotherapeutic management of advanced therapy medicinal products
    Luis Poveda-Andres, Jose
    Jose Ruiz-Caldes, Maria
    Jose Carreras-Soler, Maria
    Clopes-Estela, Ana
    Flores-Moreno, Sandra
    Garcia-Pellicer, Javier
    Giraldez-Quiroga, Miriam
    Lopez-Briz, Eduardo
    Lozano-Blazquez, Ana
    Eduardo Megias-Vericat, Juan
    Tordera-Baviera, Maria
    Valero-Garcia, Silvia
    FARMACIA HOSPITALARIA, 2022, 46 (02) : 88 - 95
  • [44] REGULATION OF THE ADVANCED THERAPY MEDICINAL PRODUCTS IN THAILAND
    Papassiripan, M.
    CYTOTHERAPY, 2018, 20 (05) : S78 - S79
  • [45] Advanced Therapy Medicinal Products - a Multiple Challenge
    Pruss, Axel
    Garritsen, Henk
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2013, 40 (06) : 384 - 385
  • [47] Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives Supporting Development in Europe
    Farkas, Andreas M.
    Mariz, Segundo
    Stoyanova-Beninska, Violeta
    Celis, Patrick
    Vamvakas, Spiros
    Larsson, Kristina
    Sepodes, Bruno
    FRONTIERS IN MEDICINE, 2017, 4
  • [48] GMP Facilities for Manufacturing of Advanced Therapy Medicinal Products for Clinical Trials: An Overview for Clinical Researchers
    Alici, Evren
    Blomberg, Pontus
    CURRENT GENE THERAPY, 2010, 10 (06) : 508 - 515
  • [49] Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective
    Salmikangas, Paula
    Schuessler-Lenz, Martina
    Ruiz, Sol
    Celis, Patrick
    Reischl, Ilona
    Menezes-Ferreira, Margarida
    Flory, Egbert
    Renner, Matthias
    Ferry, Nicolas
    REGULATORY ASPECTS OF GENE THERAPY AND CELL THERAPY PRODUCTS: A GLOBAL PERSPECTIVE, 2015, 871 : 103 - 130
  • [50] Challenges in development, market authorisation and commercialisation of advanced therapy medicinal products in Europe: A cohort study
    ten Ham, ten Renske M. T.
    Hoekman, Jarno
    Hovels, Anke M.
    Broekmans, Andre W.
    Leufkens, Hubert G. M.
    Klungel, Olaf H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 428 - 428